Treating Both Malignant and Benign Hematology with Expertise and Compassion
The Blood Cancer and Cellular Therapy Institute at Fox Chase Cancer Center, in partnership with Temple University Hospital, provides comprehensive care in bone marrow and stem cell transplantation as well as advanced cellular therapies. Our highly ranked program is dedicated to improving outcomes for patients with both malignant and benign blood disorders.
Each year, we perform approximately 200 blood and bone marrow transplants in our state-of-the-art facility designed specifically for transplant and cellular therapy patients.
Why Choose the Blood Cancer and Cellular Therapy Institute?
- Expertise on Blood Disorders – Our specialists treat both malignant conditions such as leukemia, lymphoma, and myeloma, as well as benign hematology disorders, including clotting disorders, hemoglobinopathies and other inherited or acquired non-malignant diseases.
- National Accreditations – Our program is fully accredited by the Foundation for the Accreditation of Cellular Therapy (FACT) and the National Marrow Donor Program (NMDP), recognized for excellence in transplant services.
- NCI-Designated Comprehensive Cancer Center – Fox Chase is among an elite group recognized for excellence in cancer care, research, and education.
- Experience That Matters – Our physicians have performed thousands of transplants, including allogeneic, autologous, and haploidentical procedures.
- Advanced Cellular Therapies – We offer leading-edge treatments such as CAR T-cell therapy, tumor-infiltrating lymphocytes (TIL), and bispecific antibodies to provide new hope for patients with advanced or resistant disease.
- Inclusive Care – Nearly 25% of our transplant patients are over age 65, reflecting our commitment to care across all ages.
- Bloodless Transplant Program – One of few centers in the country to offer bloodless transplant options for patients who request this specialized approach.
- Research and Clinical Trials – Our experts lead investigator-initiated studies and participate in national research groups such as ECOG-ACRIN and the Blood and Marrow Transplant Clinical Trials Network (BMT CTN), ensuring patients access the latest therapies.
- Collaborative, Multidisciplinary Care – Patients benefit from the input of multiple specialists working together to build individualized treatment plans.
- Comprehensive Support – We provide a wide range of services for patients, caregivers, and families to support the emotional, physical, and social challenges of treatment.
What To Do Next
Request an appointment online or call 888-FOX-CHASE. For general information, visit our Contact Us page.
All hospital services are provided by Temple University Hospital.
Source: 2020 Transplant Center-Specific Survival Report, Center of International Blood and Marrow Transplant Research (CIBMTR), a research collaboration between National Marrow Donor Program®/Be The Match® and Medical College of Wisconsin.
